We are live on ! Find out more
CC

CIBRA Capital Portfolio holdings

AUM $207M
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$293M
AUM Growth
+$146M
Cap. Flow
+$144M
Cap. Flow %
49.33%
Top 10 Hldgs %
84.8%
Holding
38
New
14
Increased
6
Reduced
3
Closed
13
Avg Time Held Equity + Options
0.4 quarters
Top 10 Avg Time Held Equity + Options
0.4 quarters
Top 20 Avg Time Held Equity + Options
0.5 quarters
Avg Time Held Equity only
0.5 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.5 quarters

Sector Composition

Rank Sector Weight
1 Healthcare 32.94%
2 Consumer Staples 12.67%
3 Consumer Discretionary 10.69%
4 Materials 10.16%
5 Energy 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACI icon
26
CALL
Albertsons Companies
ACI
$5.99B
– –
-75,000
Closed -$1.47M –
CVX icon
27
CALL
Chevron
CVX
$415B
– –
-78,000
Closed -$11.3M –
JNPR
28
PUT
DELISTED
Juniper Networks
JNPR
– –
-28,000
Closed -$1.05M –
SLB icon
29
SLB Ltd
SLB
$72.7B
– –
-83,452
Closed -$3.2M –
X
30
PUT
DELISTED
US Steel
X
– –
-15,000
Closed -$510K –
ALTM
31
DELISTED
Arcadium Lithium plc
ALTM
– –
-825,502
Closed -$4.23M –
MTTR
32
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
– –
-988,776
Closed -$4.69M –
ZUO
33
DELISTED
Zuora, Inc.
ZUO
– –
-209,035
Closed -$2.07M –
ROIC
34
DELISTED
Retail Opportunity Investments Corp.
ROIC
– –
-115,818
Closed -$2.01M –
SUM
35
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
– –
-19,723
Closed -$998K –
RVNC
36
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-1,139,979
Closed -$3.47M –
SMAR
37
DELISTED
Smartsheet Inc.
SMAR
– –
-428,039
Closed -$24M –
PSTX
38
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-94,495
Closed -$907K –

Similar funds

CIBRA Capital's Q1 2025 Portfolio in Review

As of Q1 2025, CIBRA Capital held 38 positions worth $293M, up 99% from $147M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

CIBRA Capital deployed $144M of net new capital in Q1 2025, opening 14 new positions and adding to 6 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 5.9% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Discover Financial Services, an estimated $2.08M trimmed.

  • CIBRA Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.
  • CIBRA Capital added most to Berry Global Group, Inc. in Q1 2025, an estimated $22.4M increase.
  • CIBRA Capital's biggest Q1 2025 reduction was Discover Financial Services, cutting an estimated $2.08M.
  • CIBRA Capital fully exited Smartsheet Inc. in Q1 2025, selling an estimated $24M.
  • CIBRA Capital's ten largest holdings make up 85% of its $293M portfolio in Q1 2025.
  • CIBRA Capital opened 14 new positions and closed 13 in Q1 2025.
  • CIBRA Capital's portfolio value rose 99% quarter-over-quarter to $293M.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.